Stem cell therapy versus T lymphocytes: friend or foe? - Wikidata - awgldk - TriplyDB

Stem cell therapy versus T lymphocytes: friend or foe?

Stem cell therapy versus T lymphocytes: friend or foe?

http://www.wikidata.org/entity/Q48490621

about

Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy.Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF.

P2860

Q42065629-324F4347-FEAA-4901-9AD5-C334662BBEA4 Q55248103-B40B400D-4B53-42FC-A61E-33AB2163FDE9

P2860

Stem cell therapy versus T lymphocytes: friend or foe?

http://www.wikidata.org/entity/Q48490621

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Stem cell therapy versus T lymphocytes: friend or foe?

@en

Stem cell therapy versus T lymphocytes: friend or foe?

@nl

type

label

Stem cell therapy versus T lymphocytes: friend or foe?

@en

Stem cell therapy versus T lymphocytes: friend or foe?

@nl

prefLabel

Stem cell therapy versus T lymphocytes: friend or foe?

@en

Stem cell therapy versus T lymphocytes: friend or foe?

@nl

P1433

Q48490621-7BAEEEBB-68BE-4310-85EF-093DF05686DD

P1476

Q48490621-6490A31C-79EF-4807-9CC0-1DCC6EE4106C

P2093

Q48490621-8FAB0DAC-B956-4154-A6C4-89DEC56B66AE

P2860

Q48490621-222143DB-33B4-4AE7-B4E5-B79D64009657

Q48490621-2301BBB4-5603-493B-B8FE-0EF7C6A3C80C

Q48490621-239807E2-B66C-4BCA-B658-BF73C1E38194

Q48490621-3AF24181-4FD5-4B5D-AC6C-0FCE27B5C327

Q48490621-4696547D-C238-42FA-9BF3-B9446E00AA51

Q48490621-4BDBF812-A75C-4DE4-82C7-F3B325E8DB12

Q48490621-705D911B-B088-43FE-858D-05F8B8A26B02

Q48490621-892F729B-0E29-413C-B081-7984041A246F

Q48490621-8E8F6EDC-6FD0-4D7A-8CA0-02F9B47B59E9

Q48490621-A5DC203E-8D2D-489F-878A-6362C858A31F

P304

Q48490621-66CE52AF-FD7D-475C-9E6D-AA51CF564BA2

P31

Q48490621-BEB64439-742D-44A4-BF01-F3DE2B36D87C

P356

Q48490621-24604BCA-31A0-4D53-AF07-9731684ABCBF

P433

Q48490621-8417D351-9B0B-4B7A-8C6D-CD4E666FB258

P478

Q48490621-2DD50050-6B58-4C78-8925-CCEFF7651A3B

P577

Q48490621-F1935A34-EBF7-42C9-B120-D028EFC6B69E

P5875

Q48490621-3ABFDFF7-6CB4-4222-AAEC-C8B1C938D6B4

P698

Q48490621-D5107D36-725D-4416-B97D-0ECD2CBFDDEC

P356

P1433

P1476

Stem cell therapy versus T lymphocytes: friend or foe?

@en

P2093

Su M Metcalfe

http://www.w3.org/2001/XMLSchema#string

P2860

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Human neural precursor cells promote neurologic recovery in a viral model of multiple sclerosis.

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.

Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease.

A special population of regulatory T cells potentiates muscle repair.

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

The unsolved enigmas of leukemia inhibitory factor.

Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.

LIF in the regulation of T-cell fate and as a potential therapeutic.

Th17 and regulatory T cell balance in autoimmune and inflammatory diseases.

P304

622-625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.1863

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266745628

http://www.w3.org/2001/XMLSchema#string

P698

25303042

http://www.w3.org/2001/XMLSchema#string